Petmed Express Inc (NASDAQ:PETS)
| 16.72 Delayed Data As of 3:59pm ET |  +0.31 / +1.89%Today’s Change | 16.03 Today|||52-Week Range 29.53 | -5.54% Year-to-Date |
| SECTOR Retail Trade | INDUSTRY Specialty Stores | MARKET CAP $384.8M |
Company Description
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Contact Information
PetMed Express, Inc. 420 South Congress Avenue Delray Beach Florida 33445 |
Employees
Shareholders
| Mutual fund holders | 50.05% |
| Other institutional | 30.35% |
| Individual stakeholders | 26.70% |
Top Executives
| Matthew N. Hulett | President, Chief Executive Officer & Director |
| Christine Chambers | Chief Financial Officer |
| Mark Moseley | Chief Technology & Information Officer |
| Carolyn Carden | Vice President-Product Management |
| Eddie Khoriaty | Dir-Pharmacy Services & Prescription Dept. Manager |
